The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Allergan plc

NYSE: AGN
Last

(U.S.) $224.00

Today's change-0.77 -0.34%
Updated August 18 9:38 AM EDT. Delayed by at least 15 minutes.
 

Allergan plc

NYSE: AGN
Last

(U.S.) $224.00

Today's change-0.77 -0.34%
Updated August 18 9:38 AM EDT. Delayed by at least 15 minutes.

Allergan plc down (U.S.)$0.77

Allergan plc is lower today, dropping (U.S.)$0.77 or 0.34% to (U.S.)$224.00. Shares have lost 3.81% over the last five days, but have gained 6.66% over the last year to date. This security has underperformed the S&P 500 by 22.27% during the last year.

Key company metrics

  • Open(U.S.) $224.40
  • Previous close(U.S.) $224.77
  • High(U.S.) $225.16
  • Low(U.S.) $224.00
  • Bid / Ask(U.S.) $223.87 / (U.S.) $224.15
  • YTD % change+6.66%
  • Volume110,934
  • Average volume (10-day)2,349,502
  • Average volume (1-month)1,943,634
  • Average volume (3-month)2,176,718
  • 52-week range(U.S.) $184.50 to (U.S.) $256.80
  • Beta1.19
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward13.81×
  • Forward PEG1.04×
  • Indicated annual dividend(U.S.) $2.80
  • Dividend yield1.25%
  • Trailing EPS(U.S.) -$11.66
Updated August 18 9:38 AM EDT. Delayed by at least 15 minutes.
S&P TSX0.61%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue4,0073,5733,8643,622
Total other revenue--------
Total revenue4,0073,5733,8643,622
Gross profit3,4573,1233,3853,160
Total cost of revenue550450480462
Total operating expense5,0714,4794,7643,889
Selling / general / administrative1,3951,1851,2771,157
Research & development1,1931,1001,340665
Depreciation / amortization1,7581,7361,6391,609
Interest expense (income), net operating--------
Unusual expense (income)176729-5
Other operating expenses, total--------
Operating income-1,064-906-900-266
Interest income (expense), net non-operating-277-290-293-324
Gain (loss) on sale of assets--------
Other--------
Income before tax-1,297-3,093-1,111-539
Income after tax-716-2,561-40-380
Income tax, total-581-532-1,071-159
Net income-726-2,565-115,220
Total adjustments to net income-70-70-70-70
Net income before extra. items-718-2,562-42-382
Minority interest-2-1-2-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-787-2,632-112-452
Inc. avail. to common incl. extra. items-796-2,635-7015,150
Diluted net income-796-2,635-7015,150
Dilution adjustment--------
Diluted weighted average shares335335356393
Diluted EPS excluding extraordinary itemsvalue per share-2.35-7.85-0.31-1.15
Dividends per sharevalue per share0.700.70--0.00
Diluted normalized EPSvalue per share-2.01-7.84-0.26-1.16